Minerva Neurosciences (NERV) Total Debt (2013 - 2017)

Minerva Neurosciences has reported Total Debt for 5 years, with the latest figure at $1.3 million in Q2 2017.

• For the quarter ending Q2 2017, Total Debt fell 78.69% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2017 stood at $1.3 million (down 78.69% YoY), and the FY2016 full-year result was $3.8 million, down 54.83% from the prior year.
• Total Debt for Q2 2017 stood at $1.3 million, down from $2.6 million in the prior quarter.
• The five-year high for Total Debt was $9.6 million in Q3 2015, with the low at $10093.0 in Q4 2013.
• Historically, Total Debt has averaged $5.3 million across 5 years, with a median of $5.6 million in 2016.
• Annual changes were most pronounced in 2015 — Total Debt soared 528.92% — and 2017, when it tumbled 78.69%.
• Minerva Neurosciences' Total Debt stood at $10093.0 in 2013, then soared by 13600.75% to $1.4 million in 2014, then soared by 514.91% to $8.5 million in 2015, then sank by 54.83% to $3.8 million in 2016, then plunged by 65.47% to $1.3 million in 2017.
• The last three Total Debt figures came in at $1.3 million (Q2 2017), $2.6 million (Q1 2017), and $3.8 million (Q4 2016), per Business Quant data.